HemaCare Corporation operates in the Health and allied services sector.
In addition to historical fundamental analyses, the complete report available to purchase compares HemaCare with three other
health care providers in North America:
sales of $20.52 million
Convalo Health International Corp
(18.95 million Canadian Dollars [US$14.19 million]
Ziopharm Oncology, Inc.
of which 100%
was Pharmaceutical Preparations).
HemaCare reported sales of $13.88 million
December of 2016.
increase of 43.0%
versus 2015, when the company's sales were $9.70 million.
This was the third consecutive year of growth at HemaCare.